One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a ...

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

Three-year Spanish study of nearly 1,000 patients draws little attention outside doctors, journalists who have long warned of ...

The "Viral Vector Manufacturing Market - Forecasts from 2024 to 2029" report has been added tAndMarkets.com's offering.The ...

The trial will include patients with newly diagnosed, treatment-naïve cancers as well as those with recurrent or metastatic disease.

Discover Moose Jaw News chatted with Dr. Darryl Falzarano, principal investigator at the University of Saskatchewan-based ...

Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the individualized cancer vaccine ...

Vaccines have to meet high effectiveness and safety standards before they are offered to the public and continue to maintain a good ongoing safety record. In Aotearoa New Zealand (NZ) Medsafe has a ...

Indonesia is conducting trials for three tuberculosis vaccines as part of its disease-eradication efforts. Health Minister ...

EuCorVac-19 EuCorVac-19, a COVID-19 vaccine candidate developed by EuBiologics and POP Biotechnologies BUFFALO, N.Y., ...